Can I stop taking Enasidenib after taking it for two months?

Patients usually continue taking enasidenib (Enasidenib) until their condition worsens or they develop unacceptable side effects. For most patients, this takes at least 6 months, and your doctor will tell you how long to continue taking ensidipine, as well as your overall treatment plan. Whether a patient can stop taking ensidipine after two months depends on the doctor's advice. Before a patient starts treatment, doctors will do blood tests to monitor side effects, and then at least every two weeks for the first 3 months of treatment.

Ensidipine is the first drug in a class of drugs calledIDH2 inhibitors to be orally targeted to treat acute myeloid leukemia (AML) by targeting the mutant IDH2 variants R140Q, R172S and R172K to block isocitrate dehydrogenase-2 (IDH2) works to help relieve the overcrowding of immature blood cells in the bone marrow. Our bodies need these cells to deliver oxygen to tissues (red blood cells), help fight infection (white blood cells), and help prevent bleeding (platelets). Approximately 8% to 19% of patients with acute myeloid leukemia have IDH2 mutations.

Ensiidi plain investigational medicine is not currently on the market in the country, nor is it covered by medical insurance. The price of ensidipine plain medicine when it is launched overseas is very high, and the price of each box may be around 30,000 yuan (the price may fluctuate due to the exchange rate). Currently, there are cheaper generic encidipine drugs produced by other pharmaceutical companies overseas. For example, the price of Specification50mg*60 tablets produced by a Bangladesh pharmaceutical factory may be around 4,000 yuan per box (the price may fluctuate due to exchange rates). Its drug ingredients are basically the same as those of the original encidipine generic drug.